Literature DB >> 20852877

Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.

Yongmei Li1, Chun Zeng, Tianyou Luo.   

Abstract

Paroxysmal dysarthria (PD) and paroxysmal dysarthria-ataxia (PDA) syndromes are uncommon symptoms of the neurological dysfunction in multiple sclerosis (MS). We describe two patients who had clinically definite MS presented with symptomatic PD and PDA syndromes, respectively, related to demyelinating lesions. In one patient, the PD symptom was the initial manifestation of an acute episode. In the other patient, the episode of dysarthria was accompanied by ataxia disorders. Both patients had midbrain lesions at or below the level of the right red nucleus on magnetic resonance imaging (MRI), confirming that this area is critically involved. Both responded well to carbamazepine (CBZ).

Entities:  

Mesh:

Year:  2010        PMID: 20852877     DOI: 10.1007/s00415-010-5748-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.

Authors:  Christophe Marcel; Mathieu Anheim; Constance Flamand-Rouvière; Françoise Heran; Pascal Masnou; Clotilde Boulay; Ivan Mari; Christine Tranchant; Emmanuel Roze
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

2.  Primary central nervous system vasculitis and moyamoya disease: similarities and differences.

Authors:  Markus Kraemer; Peter Berlit
Journal:  J Neurol       Date:  2010-05       Impact factor: 4.849

Review 3.  Speech-language pathology and dysphagia in multiple sclerosis.

Authors:  R M Merson; M I Rolnick
Journal:  Phys Med Rehabil Clin N Am       Date:  1998-08       Impact factor: 1.784

4.  Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study.

Authors:  C Solaro; G Brichetto; M A Battaglia; M Messmer Uccelli; G L Mancardi
Journal:  Neurol Sci       Date:  2005-02       Impact factor: 3.307

5.  Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine.

Authors:  O A Khan; M J Olek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

6.  Treatment of paroxysmal symptoms in multiple sclerosis with ibuprofen.

Authors:  O A Khan
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

7.  Pure dysarthria due to an insular infarction.

Authors:  Akiyuki Hiraga; Saiko Tanaka; Ikuo Kamitsukasa
Journal:  J Clin Neurosci       Date:  2010-04-18       Impact factor: 1.961

8.  Paroxysmal dysarthria and ataxia after midbrain infarction.

Authors:  M Matsui; H Tomimoto; K Sano; K Hashikawa; H Fukuyama; H Shibasaki
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  14 in total

1.  Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report.

Authors:  P Valentino; R Nisticò; D Pirritano; G Bilotti; F Del Giudice; M Sturniolo; A Quattrone
Journal:  J Neurol       Date:  2011-01-25       Impact factor: 4.849

2.  Clinically isolated syndrome presenting as paroxysmal dysarthria: a rare but typical presentation.

Authors:  Rajendra Singh Jain; Rahul Handa; Arvind Vyas; Swayam Prakash; Kadam Nagpal
Journal:  Neurol Sci       Date:  2014-03-26       Impact factor: 3.307

Review 3.  Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt; Katharina Feil
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

Review 4.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

5.  Diagnosis and misdiagnosis of cerebrovascular disease.

Authors:  Vasileios-Arsenios Lioutas; Shruti Sonni; Louis R Caplan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06

6.  Harry Lee Parker and paroxysmal dysarthria and ataxia.

Authors:  James P Klaas; David B Burkholder; Wolfgang Singer; Christopher J Boes
Journal:  Neurology       Date:  2013-01-15       Impact factor: 9.910

7.  Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.

Authors:  Luca Codeluppi; Guido Bigliardi; Annalisa Chiari; Stefano Meletti
Journal:  BMJ Case Rep       Date:  2013-10-16

8.  Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.

Authors:  Kurosh Gharagozli; Leila Poorsaadat; Ali Amini Harandi; Hossein Pakdaman; Hossein Kalanie
Journal:  Iran J Neurol       Date:  2012

9.  Demyelination and remyelination detected in an alternative cuprizone mouse model of multiple sclerosis with 7.0 T multiparameter magnetic resonance imaging.

Authors:  Shuang Ding; Yu Guo; Xiaoya Chen; Silin Du; Yongliang Han; Zichun Yan; Qiyuan Zhu; Yongmei Li
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

10.  Vestibular paroxysmia: Diagnostic criteria.

Authors:  Michael Strupp; Jose A Lopez-Escamez; Ji-Soo Kim; Dominik Straumann; Joanna C Jen; John Carey; Alexandre Bisdorff; Thomas Brandt
Journal:  J Vestib Res       Date:  2016       Impact factor: 2.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.